212 related articles for article (PubMed ID: 15659932)
1. Abnormal selective cytology results predict recurrence of upper-tract transitional-cell carcinoma treated with ureteroscopic laser ablation.
Boorjian S; Ng C; Munver R; Palese MA; Sosa RE; Vaughan ED; Del Pizzo JJ; Scherr DS
J Endourol; 2004 Nov; 18(9):912-6. PubMed ID: 15659932
[TBL] [Abstract][Full Text] [Related]
2. Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma.
Boorjian S; Ng C; Munver R; Palese MA; Vaughan ED; Sosa RE; Del Pizzo JJ; Scherr DS
Urology; 2005 Aug; 66(2):283-7. PubMed ID: 16098357
[TBL] [Abstract][Full Text] [Related]
3. Retrograde endoscopic laser therapy and ureteroscopic surveillance for transitional cell carcinoma of the upper urinary tract.
Mugiya S; Ozono S; Nagata M; Otsuka A; Takayama T; Nagae H
Int J Urol; 2006 Jan; 13(1):1-6. PubMed ID: 16448423
[TBL] [Abstract][Full Text] [Related]
4. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
[TBL] [Abstract][Full Text] [Related]
5. Correlation of upper-tract cytology, retrograde pyelography, ureteroscopic appearance, and ureteroscopic biopsy with histologic examination of upper-tract transitional cell carcinoma.
Williams SK; Denton KJ; Minervini A; Oxley J; Khastigir J; Timoney AG; Keeley FX
J Endourol; 2008 Jan; 22(1):71-6. PubMed ID: 18315477
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
7. The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma.
Gurbuz C; Youssef RF; Shariat SF; Lotan Y; Wood CG; Sagalowsky AI; Zigeuner R; Kikuchi E; Weizer A; Raman JD; Remzi M; Roscigno M; Montorsi F; Bolenz C; Kassouf W; Margulis V
J Endourol; 2011 May; 25(5):775-9. PubMed ID: 21388245
[TBL] [Abstract][Full Text] [Related]
8. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
Chen GL; Bagley DH
J Urol; 2000 Oct; 164(4):1173-6. PubMed ID: 10992360
[TBL] [Abstract][Full Text] [Related]
9. Ureterorenoscopic biopsy and urinary cytology according to the 2004 WHO classification underestimate tumor grading in upper urinary tract urothelial carcinoma.
Straub J; Strittmatter F; Karl A; Stief CG; Tritschler S
Urol Oncol; 2013 Oct; 31(7):1166-70. PubMed ID: 22300757
[TBL] [Abstract][Full Text] [Related]
10. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival.
Brausi MA; Gavioli M; De Luca G; Verrini G; Peracchia G; Simonini G; Viola M
Eur Urol; 2007 Nov; 52(5):1414-8. PubMed ID: 17507148
[TBL] [Abstract][Full Text] [Related]
11. Retrograde endoscopic laser therapy for transitional cell carcinoma of the upper urinary tract.
Mugiya S; Maruyama S; Nagata M; Hadano S; Nagae H
Int J Urol; 2003 Jul; 10(7):371-6. PubMed ID: 12823691
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of upper urinary tract transitional cell carcinoma: the role of ureteroscopy, retrograde pyelography, cytology and urinalysis.
Chen GL; El-Gabry EA; Bagley DH
J Urol; 2000 Dec; 164(6):1901-4. PubMed ID: 11061876
[TBL] [Abstract][Full Text] [Related]
13. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
Rouprêt M; Hupertan V; Traxer O; Loison G; Chartier-Kastler E; Conort P; Bitker MO; Gattegno B; Richard F; Cussenot O
Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
[TBL] [Abstract][Full Text] [Related]
14. Current practice patterns in urologic management of upper-tract transitional-cell carcinoma.
Razdan S; Johannes J; Cox M; Bagley DH
J Endourol; 2005 Apr; 19(3):366-71. PubMed ID: 15865529
[TBL] [Abstract][Full Text] [Related]
15. Ureteroscopic laser treatment of upper urinary tract neoplasms.
Bagley DH; Grasso M
World J Urol; 2010 Apr; 28(2):143-9. PubMed ID: 20229233
[TBL] [Abstract][Full Text] [Related]
16. Bladder tumor recurrence after primary surgery for transitional cell carcinoma of the upper urinary tract.
Oehlschläger S; Baldauf A; Wiessner D; Gellrich J; Hakenberg OW; Wirth MP
Urol Int; 2004; 73(3):209-11. PubMed ID: 15539838
[TBL] [Abstract][Full Text] [Related]
17. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
[TBL] [Abstract][Full Text] [Related]
18. Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma.
Walton TJ; Sherwood BT; Parkinson RJ; Obakponovwe O; Thomas SA; Taylor MC; England RC; Lemberger RJ
J Urol; 2009 Feb; 181(2):532-9. PubMed ID: 19084866
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in laser treatment of upper urinary tract urothelial tumours.
Niţă G; Georgescu D; Mulţescu R; Draguţescu M; Mihai B; Geavlete B; Persu C; Geavlete P
J Med Life; 2012 Feb; 5(1):33-8. PubMed ID: 22574085
[TBL] [Abstract][Full Text] [Related]
20. Evolving management of upper-tract transitional-cell carcinoma at a tertiary-care center.
Murphy DP; Gill IS; Streem SB
J Endourol; 2002 Sep; 16(7):483-7. PubMed ID: 12396441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
